Avenue Therapeutics Inc (ATXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Avenue Therapeutics Inc (Avenue Therapeutics), a subsidiary of Fortress Biotech Inc, is a specialty pharmaceutical company that focuses on the development and commercialization of an intravenous (IV) tramadol for the management of severe postoperative pain in adults. The companys IV Tramadol is a synthetic dual-acting opioid that fills the gap in the acute pain market between IV acetaminophen/NSAIDs and IV conventional narcotics. It develops products in the acute/intensive care hospital market. The company also conducts pivotal Phase 3 trials for IV Tramadol in patients with severe postoperative pain. Avenue Therapeutics is headquartered in New York, the US.

Avenue Therapeutics Inc (ATXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Avenue Therapeutics Raises USD0.2 Million in Venture Financing 10
Equity Offering 11
Avenue Therapeutics Plans to Raise up to USD75 Million in Public Offering of Securities 11
Avenue Therapeutics Raises USD38 Million in IPO 12
Avenue Therapeutics Inc - Key Competitors 14
Avenue Therapeutics Inc - Key Employees 15
Avenue Therapeutics Inc - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Aug 14, 2018: Avenue Therapeutics announces second quarter 2018 financial results 17
May 03, 2018: Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights 18
Nov 09, 2017: Avenue Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights 19
Aug 11, 2017: Avenue Therapeutics Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights 20
Corporate Communications 21
Jul 03, 2017: Fortress Biotech Announces Appointment of Lucy Lu, MD, as President and Chief Executive Officer of Subsidiary Avenue Therapeutics 21
Jul 03, 2017: Fortress Biotech names president and CEO of Avenue Therapeutics 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables


Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avenue Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Avenue Therapeutics Raises USD0.2 Million in Venture Financing 10
Avenue Therapeutics Plans to Raise up to USD75 Million in Public Offering of Securities 11
Avenue Therapeutics Raises USD38 Million in IPO 12
Avenue Therapeutics Inc, Key Competitors 14
Avenue Therapeutics Inc, Key Employees 15

List Of Figures


Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Avenue Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Avenue Therapeutics Inc (ATXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Avenue Therapeutics Inc (Avenue Therapeutics), a subsidiary of Fortress Biotech Inc, is a specialty pharmaceutical company that focuses on the development and commercialization of an intravenous (IV) tramadol for the

USD 250 View Report

Tenth Avenue Petroleum Corp (TPC) - Oil and Gas - Deals and Alliances Profile

Tenth Avenue Petroleum Corp (TPC), formerly Jadela Oil Corp is an oil and gas company that explores and develops petroleum and natural gas properties in Western Canada. The company explores

USD 250 View Report

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2019 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products

USD 750 View Report

Pear Therapeutics Inc - Product Pipeline Analysis, 2019 Update

Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD)

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available